Ronald Busuttil
Transplant Surgery Los Angeles, CA Medical Doctor
NPI 1639103906 CMS profile 1007826
200 Ucla Medical Plz Ste 214, Los Angeles, CA 90095
General payments
$241
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$321,730
Through program year 2024, Ronald Busuttil of Los Angeles, CA is reported in the CMS Open Payments database as having received $241 across 5 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $321,730 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 18th percentile of Transplant Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $36 | 1 | |
| 2023 | General | $98 | 1 | |
| 2022 | General | $107 | 3 |
Beside peers
- Ronald Busuttil
- Transplant Surgery median
- Middle half of Transplant Surgery
- National median
In program year 2025, general payments to Ronald Busuttil were reported at $0. Among 555 Transplant Surgery profiles paid that year, the median was $421 and the middle half received between $116 and $2,169.
Show as a table
| Year | Ronald Busuttil | Transplant Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $203 | $77–$1,249 | $163 |
| 2020 | $0 | $149 | $52–$1,366 | $114 |
| 2021 | $0 | $168 | $73–$2,008 | $132 |
| 2022 | $107 | $213 | $94–$1,464 | $149 |
| 2023 | $98 | $262 | $93–$1,458 | $160 |
| 2024 | $36 | $354 | $126–$2,252 | $164 |
| 2025 | $0 | $421 | $116–$2,169 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
5 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Transplant Surgery in California
Elizabeth Squiers
Transplant Surgery · Half Moon Bay, CA
Myron Tong
Transplant Surgery · Pasadena, CA
Robert Redfield
Transplant Surgery · Orange, CA
Yuri Genyk
Transplant Surgery · Los Angeles, CA
Angeles Baquerizo
Transplant Surgery · La Jolla, CA
Navpreet Kaur
Transplant Surgery · Los Angeles, CA
Related records
Transplant Surgery in California
Practitioners in the same specialty and state, ranked by reported value.
All Transplant Surgery
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.